純利益 & Net Margin
RSGK PT. Kedoya Adyaraya Tbk
785.575,00
845
-5 (-0,59%)
2019
n/a
2020
n/a
2021
52.781 (12.13%)
2022
26.179 (7.29%)
2023
25.188 (6.75%)
IRRA PT. Itama Ranoraya Tbk
738.657,00
476
-4 (-0,83%)
2019
33.205 (11.79%)
2020
60.521 (10.73%)
2021
112.155 (8.5%)
2022
48.004 (6.37%)
2023
5.198 (0.75%)
PEVE PT. Penta Valent Tbk
504.967,00
286
-4 (-1,38%)
2019
4.983 (0.35%)
2020
269 (0.02%)
2021
19.276 (1.08%)
2022
23.546 (1.1%)
2023
36.171 (1.46%)
RSCH PT. Charlie Hospital Semarang Tbk
503.500,00
190
-18 (-8,65%)
2019
n/a
2020
n/a
2021
n/a
2022
n/a
2023
-1.111 (-2.64%)
INAF PT. Indofarma Tbk
473.863,00
149
-2 (-1,33%)
2019
7.961 (0.59%)
2020
27 (0%)
2021
-37.580 (-1.29%)
2022
-428.462 (-37.45%)
2023
n/a
IKPM PT. Ikapharmindo Putramas Tbk
367.256,00
218
-6 (-2,68%)
2019
n/a
2020
n/a
2021
n/a
2022
16.577 (4.16%)
2023
15.337 (3.48%)
DGNS PT. Diagnos Laboratorium Utama Tbk
287.499,00
222
-6 (-2,63%)
2019
n/a
2020
52.686 (28.76%)
2021
64.303 (21.28%)
2022
12.664 (6.57%)
2023
-13.655 (-9.37%)
PEHA PT. Phapros Tbk
275.520,00
328
+2 (+0,61%)
2019
102.033 (9.23%)
2020
7.154 (0.73%)
2021
11.070 (1.05%)
2022
28.069 (2.4%)
2023
5.959 (0.59%)
HALO PT. Haloni Jane Tbk
259.900,00
46
+1 (+2,22%)
2019
n/a
2020
n/a
2021
n/a
2022
n/a
2023
16.996 (7.35%)
PRIM PT. Royal Prima Tbk
182.429,00
54
-1 (-1,82%)
2019
2.396 (1.38%)
2020
38.169 (14.65%)
2021
75.433 (12.57%)
2022
21.589 (8.24%)
2023
-2.746 (-1.03%)
MMIX PT. Multi Medika Internasional Tbk
122.405,00
51
-1 (-2,00%)
2019
n/a
2020
352 (23.75%)
2021
10.331 (25.52%)
2022
23.668 (13.52%)
2023
16.512 (9.43%)
MEDS PT. Hetzer Medical Indonesia Tbk
78.125,00
50
0 (0%)
2019
n/a
2020
n/a
2021
n/a
2022
237 (0.63%)
2023
-3.570 (-15.71%)
SCPI PT. Organon Pharma Indonesia Tbk
0
0
0 (0%)
2019
112.652 (6.12%)
2020
218.362 (7.55%)
2021
118.691 (5.5%)
2022
174.782 (7.47%)
2023
187.701 (6.83%)